| Sep 2 |
Does Arcturus Therapeutics (ARCT) Have the Potential to Rally 216.35% as Wall Street Analysts Expect?
|
| Sep 2 |
SNY's MS Drug Meets Goal in One Phase III Study; Misses in Two Others
|
| Aug 27 |
Rhythm Stock Up as FDA Accepts Obesity Drug sNDA for Younger Kids
|
| Aug 26 |
AstraZeneca (AZN) Denies Rumors About UK Facility Relocation
|
| Aug 26 |
Sutro Biopharma (STRO) Rises 9% in the Past Week: Here's Why
|
| Aug 26 |
J&J (JNJ) Gets EU Approval for Bladder Cancer Drug Balversa
|
| Aug 23 |
What Makes Arcturus Therapeutics (ARCT) a New Strong Buy Stock
|
| Aug 23 |
Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study
|
| Aug 22 |
Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday
|
| Aug 22 |
Bristol Myers' (BMY) HCC Combo Drug Accepted for FDA Review
|
